Fondo de planta borrosa de tratamiento de cáncer de mecc

Prevención del cáncer de mama

Prevención del cáncer de mama

En el Montefiore Einstein Comprehensive Cancer Center, designado por el NCI como centro integral del cáncer, nos centramos en prevenir que el cáncer comience y detectarlo lo antes posible, cuando el tratamiento es más fácil y eficaz.

Become familiar with your personal risk factors for breast cancer and take steps to lower your risk of the disease. Rest assured, our world-renowned breast cancer specialists and researchers are dedicated to championing new ways to prevent, detect and treat breast cancer in New York and beyond, especially for women and men who may be at a higher risk for developing the condition.

There are many things you can do to lower your chances of getting breast cancer. Eating a healthy diet, living an active lifestyle, not smoking and avoiding secondhand smoke, and limiting the amount of alcohol you drink not only lowers your risk of all types of cancer but can improve your overall health and well-being. It’s also important to understand your personal and family health history and attend regular visits with a primary care provider. Talk to your doctor about the breast cancer screenings that may be right for you. At Montefiore Einstein Comprehensive Cancer Center, you can get accurate, timely answers through breast cancer screenings, including mammograms, ultrasound, and genetic testing and counseling services.

For more than 50 years, Montefiore Einstein Comprehensive Cancer Center has been a leader in the research diagnosis and treatment of over 200 types of cancer. Turn to us for expert cancer screening and prevention.

Logotipo de MEBCC
Acuda al Centro de Salud Mamaria para recibir atención médica coordinada especializada en salud mamaria en un entorno moderno, atenderse con algunos de los mejores especialistas multidisciplinarios del país y obtener toda la información y orientación personalizada que necesita para dar sus próximos pasos.

Breast Cancer Prevention (PDQ®)–Patient Version

¿Qué es la prevención?

Cancer prevention is action taken to lower the chance of getting cancer. By preventing cancer, the number of new cases of cancer in a group or population is lowered. Hopefully, this will reduce the burden of cancer and lower the number of deaths caused by cancer.

Cancer is not a single disease but a group of related diseases. Our genes, lifestyle, and the environment around us work together to increase or decrease our risk of getting cancer. Each person’s cancer risk is made up of a combination of these factors.

Para prevenir la aparición de nuevos cánceres, los científicos analizan los factores de riesgo y los factores protectores . Cualquier cosa que aumente las posibilidades de desarrollar cáncer se denomina factor de riesgo de cáncer; Cualquier cosa que reduzca las posibilidades de desarrollar cáncer se llama factor protector contra el cáncer.

Some risk factors for cancer can be avoided, but many cannot. For example, both smoking and inheriting certain genes are risk factors for some types of cancer, but only smoking can be avoided. Regular exercise and a healthy diet may be protective factors for some types of cancer. Avoiding risk factors and increasing protective factors may lower your risk, but it does not mean that you will not get cancer.

Se están estudiando diferentes formas de prevenir el cáncer, entre ellas:

  • Cambiar el estilo de vida o los hábitos alimentarios.
  • Evitar cosas que se sabe que causan cáncer.
  • Tomar medicamentos para tratar una afección precancerosa o para evitar que se desarrolle un cáncer.
  • Having risk-reducing surgery.

Información general sobre el cáncer de mama

Puntos clave

  • El cáncer de mama es una enfermedad en la que se forman células malignas (cancerosas) en los tejidos de la mama.
  • El cáncer de mama es la segunda causa principal de muerte por cáncer en las mujeres estadounidenses.

El cáncer de mama es una enfermedad en la que se forman células malignas (cancerosas) en los tejidos de la mama.

The breast is made up of lobes and ducts. Each breast has 15 to 20 sections called lobes, which have many smaller sections called lobules. Lobules end in dozens of tiny bulbs that can make milk. The lobes, lobules, and bulbs are linked by thin tubes called ducts.

Dibujo de la anatomía del seno femenino que muestra los ganglios linfáticos, el pezón, la areola, la pared torácica, las costillas, el músculo, el tejido adiposo, el lóbulo, los conductos y los lóbulos.

Anatomía de la mama femenina. El pezón y la areola se muestran en la parte exterior del seno. También se muestran los ganglios linfáticos, lóbulos, lobulillos, conductos y otras partes del interior de la mama.

Cada seno también tiene vasos sanguíneos y vasos linfáticos . Los vasos linfáticos transportan un líquido acuoso casi incoloro llamado linfa . Los vasos linfáticos transportan linfa entre los ganglios linfáticos . Los ganglios linfáticos son estructuras pequeñas con forma de frijol que filtran la linfa y almacenan glóbulos blancos que ayudan a combatir infecciones y enfermedades. Se encuentran grupos de ganglios linfáticos cerca del seno en la axila (debajo del brazo), encima de la clavícula y en el pecho.

Otros resúmenes del PDQ que contienen información relacionada con el cáncer de mama incluyen:

El cáncer de mama es la segunda causa principal de muerte por cáncer en las mujeres estadounidenses.

Women in the United States get breast cancer more than any other type of cancer except for skin cancer. Breast cancer is second to lung cancer as a cause of cancer death in American women. Breast cancer rates in women increased gradually for many years until the early 2000s and then decreased rapidly, coinciding with a drop in postmenopausal hormone therapy use. However, since 2005, there has been a small but steady increase in breast cancer rates in women. Deaths from breast cancer have declined by 42% as of 2021. However, breast cancer deaths in Black women remain about 40% higher than in White women. Breast cancer also occurs in men, but the number of new cases is small.

Prevención del cáncer de mama

Puntos clave

  • Evitar los factores de riesgo y aumentar los factores de protección puede ayudar a prevenir el cáncer.
  • Los siguientes son riesgo factors for breast cancer:
    • Older age
    • A personal history of breast cancer or benign (noncancer) breast disease
    • Inherited risk of breast cancer
    • Dense breast tissue
    • Reproductive history resulting in greater exposure to estrogen
    • Taking hormone therapy for symptoms of menopause
    • Radiation therapy to the breast or chest
    • Obesidad
    • Beber alcohol
  • Los siguientes son protector factors for breast cancer:
    • Reproductive history resulting in less exposure to estrogen
    • Taking selective estrogen receptor modulators or aromatase inhibitors and inactivators
      • Selective estrogen receptor modulators
      • Aromatase inhibitors and inactivators
    • Risk-reducing or prophylactic mastectomy
    • Ovarian ablation
    • Getting enough exercise
  • It is not clear whether the following affect the risk of breast cancer:
    • Hormonal contraceptives
    • Chemicals in the environment
  • Studies have shown that some factors have little or no effect on the risk of breast cancer.
  • Los ensayos clínicos de prevención del cáncer se utilizan para estudiar formas de prevenir el cáncer.
  • New ways to prevent breast cancer are being studied in clinical trials.

Evitar los factores de riesgo y aumentar los factores de protección puede ayudar a prevenir el cáncer.

Evitar los factores de riesgo del cáncer puede ayudar a prevenir ciertos tipos de cáncer. Entre los factores de riesgo se incluyen el tabaquismo, el sobrepeso y la falta de ejercicio. Aumentar los factores de protección, como dejar de fumar y hacer ejercicio, también puede ayudar a prevenir algunos tipos de cáncer. Hable con su médico u otro profesional de la salud sobre cómo puede reducir el riesgo de cáncer.

NCI's Breast Cancer Risk Assessment Tool uses a woman's risk factors to estimate her risk for breast cancer during the next five years and up to age 90. This online tool is meant to be used by a health care provider. For more information on breast cancer risk, call 1-800-4-CANCER.

The following are risk factors for breast cancer:

Older age

Besides being a woman, older age is the main risk factor for breast cancer. The chance of getting breast cancer increases as a woman gets older. A 30-year-old woman has about a 1 in 175 chance of being diagnosed with breast cancer in the next 10 years, while a 70-year-old woman has a 1 in 9 chance of getting the disease during the same time period.

Women aged 50 to 69 years who have screening mammograms have a lower chance of dying from breast cancer than women who do not have screening mammograms. Screening by mammography decreases breast cancer deaths by identifying cases for treatment at an earlier stage.

A personal history of breast cancer or benign (noncancer) breast disease

Women with any of the following have an increased risk of breast cancer:

Inherited risk of breast cancer

Women with a family history of breast cancer in a first-degree relative (mother, sister, or daughter) have an increased risk of breast cancer.

Women who have inherited changes in the BRCA1 or BRCA2 gene or in certain other genes have a higher risk of breast cancer. The risk of breast cancer caused by inherited gene changes depends on the type of gene mutation, family history of cancer, and other factors.

Dense breast tissue

Having breast tissue that is dense on a mammogram is a factor in breast cancer risk. The level of risk depends on how dense the breast tissue is. Women with very dense breasts have a higher risk of breast cancer than women with low breast density.

Increased breast density is often an inherited trait, but it may also occur in women who have not had children, have a first pregnancy late in life, take postmenopausal hormones, or drink alcohol. To learn more, visit Dense Breasts: Answers to Commonly Asked Questions.

Reproductive history resulting in greater exposure to estrogen

Estrogen is a hormone made by the body. It helps the body develop and maintain female sex characteristics. Being exposed to estrogen over a long time may increase the risk of breast cancer. Estrogen levels are highest during the years a woman is menstruating.

The following factors in a woman's reproductive history increase the length of time her breast tissue is exposed to estrogen and may increase the risk of breast cancer:

  • Early menstruation: Beginning to have menstrual periods before age 12 increases the number of years the breast tissue is exposed to estrogen.
  • Starting menopause at a later age: The more years a woman menstruates, the longer her breast tissue is exposed to estrogen.
  • Older age at birth of first child or never having given birth: Pregnancy lowers a woman’s lifetime number of menstrual cycles. Breast tissue is exposed to more estrogen for longer periods of time in women who become pregnant for the first time after age 35 or who never become pregnant.

Taking hormone therapy for symptoms of menopause

Hormones, such as estrogen and progesterone, can be made into a pill form in a laboratory. Estrogen, progestin, or both may be given to replace the estrogen no longer made by the ovaries in postmenopausal women or women who have had their ovaries removed. This is called menopausal hormone therapy (MHT) or hormone replacement therapy (HRT). Estrogen therapy that began close to the time of menopause is associated with an increased risk of developing breast cancer. Estrogen therapy that began at or after menopause is associated with an increased risk of developing endometrial cancer and total cardiovascular disease, especially stroke. The risk of breast cancer does not decrease after women stop taking estrogen.

Combination hormone therapy (HT) is estrogen combined with progestin. This type of HT increases the risk of breast cancer. Studies show that when women stop taking estrogen combined with progestin, the risk of breast cancer decreases.

Radiation therapy to the breast or chest

Radiation therapy to the chest for the treatment of cancer increases the risk of breast cancer, starting 10 years after treatment. The risk of breast cancer depends on the dose of radiation and the age at which it was given. The risk is highest if radiation treatment was used during puberty, when breasts are forming.

Radiation therapy to treat cancer in one breast does not appear to increase the risk of cancer in the other breast.

For women who have inherited changes in the BRCA1 or BRCA2 gene, exposure to radiation, such as that from chest x-rays, may further increase the risk of breast cancer, especially in women who had x-rays before age 20.

Obesidad

Obesity increases the risk of breast cancer, especially in postmenopausal women who have not used HT.

Beber alcohol

Drinking alcohol increases the risk of breast cancer. The level of risk rises as the amount of alcohol consumed rises.

The following are protective factors for breast cancer:

Reproductive history resulting in less exposure to estrogen

A woman’s reproductive history can affect the length of time her breast tissue is exposed to estrogen. Early onset of menstruation, late onset of menopause, later age at first pregnancy, and never having given birth have been linked to an increase in estrogen exposure and breast cancer risk. The following reproductive factors decrease the length of time a woman's breast tissue is exposed to estrogen and may help prevent breast cancer:

  • Early pregnancy: Estrogen levels are lower during pregnancy. In one study, women who had a full-term pregnancy before age 20 had a lower risk of breast cancer than women who did not have children or who gave birth to their first child after age 35.
  • Breast-feeding: Estrogen levels may remain lower while a woman is breast-feeding. Women who breastfed have a lower risk of breast cancer than women who have had children but did not breastfeed.

Taking selective estrogen receptor modulators or aromatase inhibitors and inactivators

Selective estrogen receptor modulators

Tamoxifen and raloxifene belong to the family of drugs called selective estrogen receptor modulators (SERMs). SERMs act like estrogen on some tissues in the body, but block the effect of estrogen on other tissues.

Treatment with tamoxifen lowers the risk of estrogen receptor-positive (ER-positive) breast cancer and DCIS in premenopausal and postmenopausal women at high risk. Tamoxifen is also used to treat metastatic breast cancer and to prevent cancer from recurring after surgery to remove breast tumors. Treatment with raloxifene also lowers the risk of breast cancer in postmenopausal women. With either drug, the reduced risk lasts for several years or longer after treatment is stopped. Lower rates of broken bones have been noted in patients taking raloxifene.

Taking tamoxifen increases the risk of hot flashes, endometrial cancer, stroke, cataracts, and blood clots (especially in the lungs and legs). The risk of having these problems increases markedly in women older than 50 years compared with younger women. Premenopausal women who have a high risk of breast cancer may benefit the most from taking a low dose of tamoxifen, which may decrease breast cancer risk while also reducing some side effects of the drug. The risk of endometrial cancer lasts for 5 years after tamoxifen is stopped, but the risk of cataracts or blood clots does not last long. Talk with your doctor about the risks and benefits of taking this drug.

Taking raloxifene increases the risk of blood clots in the lungs and legs but does not appear to increase the risk of endometrial cancer. In postmenopausal women with osteoporosis (decreased bone density), raloxifene lowers the risk of breast cancer for women who have a high or low risk of breast cancer. It is not known if raloxifene would have the same effect in women who do not have osteoporosis. Talk with your doctor about the risks and benefits of taking this drug.

Other SERMs are being studied in clinical trials.

Aromatase inhibitors and inactivators

Aromatase inhibitors (anastrozole, letrozole) and inactivators (exemestane) lower the risk of recurrence and of new breast cancers in women who have a history of breast cancer. Aromatase inhibitors also decrease the risk of breast cancer in women with the following conditions:

  • Postmenopausal women with a personal history of breast cancer.
  • Women with no personal history of breast cancer who are 60 years and older, have a history of DCIS with mastectomy, or have a high risk of breast cancer based on the Gail model tool (a tool used to estimate the risk of breast cancer).

In women with an increased risk of breast cancer, taking aromatase inhibitors decreases the amount of estrogen made by the body. Before menopause, estrogen is made by the ovaries and other tissues in a woman's body, including the brain, fat tissue, and skin. After menopause, the ovaries stop making estrogen, but the other tissues do not. Aromatase inhibitors block the action of an enzyme called aromatase, which is used to make all of the body's estrogen. Aromatase inactivators stop the enzyme from working.

Possible harms from taking aromatase inhibitors include muscle and joint pain, osteoporosis, hot flashes, and feeling very tired.

Risk-reducing or prophylactic mastectomy

Some women who have a high risk of breast cancer may choose to have a risk-reducing or prophylactic mastectomy (the removal of one or both breasts when there are no signs of cancer). After surgery, the risk of breast cancer becomes much lower in these women, and most feel less anxious about their risk of breast cancer. Some women diagnosed with breast cancer may decide to have a healthy breast removed at the same time the breast with cancer is removed. This is called contralateral prophylactic mastectomy. However, it is very important to have a cancer risk assessment and counseling about the different ways to prevent breast cancer before making any decision about surgery.

Ovarian ablation

The ovaries make most of the estrogen that is made by the body. Treatments that stop or lower the amount of estrogen made by the ovaries include surgery to remove the ovaries, radiation therapy, or taking certain drugs. This is called ovarian ablation.

Premenopausal women who have a high risk of breast cancer due to certain changes in the BRCA1 or BRCA2 gene may choose to have a risk-reducing oophorectomy (the removal of both ovaries when there are no signs of cancer). This decreases the amount of estrogen made by the body and lowers the risk of breast cancer. Risk-reducing oophorectomy also lowers the risk of breast cancer in average-risk premenopausal women and in women with an increased risk of breast cancer due to radiation to the chest. However, it is very important to have a cancer risk assessment and counseling before making this decision. The sudden drop in estrogen levels may cause the symptoms of menopause to begin. These include hot flashes, trouble sleeping, anxiety, and depression. Long-term effects include decreased sex drive, vaginal dryness, and decreased bone density.

Getting enough exercise

Women who take part in physical exercise have a lower risk of breast cancer.

It is not clear whether the following affect the risk of breast cancer:

Hormonal contraceptives

Hormonal contraceptives contain estrogen or estrogen and progestin. Some studies have shown that women who are current or recent users of hormonal contraceptives may have a slight increase in breast cancer risk. Other studies have not shown an increased risk of breast cancer in women using hormonal contraceptives.

In one study, the risk of breast cancer slightly increased the longer a woman used hormonal contraceptives. Another study showed that the slight increase in breast cancer risk decreased over time when women stopped using hormonal contraceptives.

More studies are needed to know whether hormonal contraceptives affect a woman's risk of breast cancer.

Chemicals in the environment

Scientists are studying whether exposure to chemicals in the environment may increase a woman's risk of breast cancer. Studies of this kind can be difficult to conduct and interpret for many reasons:

  • It is hard to determine the specific chemicals people have been exposed to in the past. It can take decades after a potential exposure before cancer develops, and a person may not be aware of or remember the past exposure.
  • Even if a chemical is shown in a laboratory test to cause cancer, this does not necessarily mean it will cause cancer in people exposed to that chemical in the environment. A chemical may cause cancer when tested at high levels in laboratory studies but not at the lower levels seen in the environment.
  • Individual chemicals are likely to cause only a small increase in risk, and it can be difficult to detect that increase in the context of the other factors that may influence a woman's risk of breast cancer.

These reasons make it hard to know which chemicals, if any, may increase the risk of breast cancer. More studies are needed to know whether chemicals in the environment affect a woman's risk of breast cancer. To learn more, visit Environmental Carcinogens and Cancer Risk.

Studies have shown that some factors have little or no effect on the risk of breast cancer.

The following have little or no effect on the risk of breast cancer:

Los ensayos clínicos de prevención del cáncer se utilizan para estudiar formas de prevenir el cáncer.

Los ensayos clínicos de prevención del cáncer se utilizan para estudiar formas de reducir el riesgo de desarrollar ciertos tipos de cáncer. Algunos ensayos de prevención del cáncer incluyen a personas sanas que pueden o no tener un mayor riesgo de padecer cáncer. Otros ensayos de prevención incluyen a personas que han tenido cáncer y están tratando de prevenir la recurrencia o un segundo cáncer.

El propósito de algunos ensayos clínicos de prevención del cáncer es determinar si las acciones que toman las personas pueden prevenir el cáncer. Estos pueden incluir comer frutas y verduras, hacer ejercicio, dejar de fumar o tomar ciertos medicamentos, vitaminas, minerales o complementos alimenticios.

New ways to prevent breast cancer are being studied in clinical trials.

La información sobre los ensayos clínicos patrocinados por el NCI se puede encontrar en la página web de búsqueda de ensayos clínicos del NCI. Los ensayos clínicos patrocinados por otras organizaciones se pueden encontrar en el sitio web ClinicalTrials.gov .

Información sobre este resumen del PDQ

Acerca del PDQ

Physician Data Query (PDQ) es la base de datos integral sobre el cáncer del Instituto Nacional del Cáncer (NCI). La base de datos del PDQ contiene resúmenes de la última información publicada sobre prevención, detección, genética, tratamiento, atención médica de apoyo y medicina complementaria y alternativa relacionada con el cáncer. La mayoría de los resúmenes se redactan en dos versiones. Las versiones para profesionales de la salud contienen información detallada escrita en lenguaje técnico. Las versiones para pacientes están redactadas en un lenguaje fácil de entender, que no es técnico. Ambas versiones contienen información sobre el cáncer correcta y actualizada. La mayoría de las versiones también están disponibles en español.

El PDQ es un servicio del NCI. El NCI es parte de los Institutos Nacionales de Salud (NIH), que son el centro de investigación biomédica del Gobierno federal. Los resúmenes del PDQ se basan en una revisión independiente de la literatura médica. No son declaraciones de políticas del NCI ni de los NIH.

Propósito de este resumen

This PDQ cancer information summary has current information about breast cancer prevention. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.

Revisores y actualizaciones

Los consejos editoriales escriben los resúmenes de información sobre el cáncer del PDQ y los mantienen actualizados. Estos consejos están conformados por equipos de especialistas en el tratamiento del cáncer y otras especialidades relacionadas con esta enfermedad. Los resúmenes se revisan periódicamente y se modifican cuando hay información nueva. La fecha de actualización al pie de cada resumen indica cuándo fue el cambio más reciente.

La información contenida en este resumen para pacientes se tomó de la versión para profesionales de la salud, que el Consejo editorial del PDQ sobre detección y prevención revisa con regularidad y actualiza según sea necesario.

Información sobre ensayos clínicos

Un ensayo clínico es un estudio para responder a una pregunta científica; por ejemplo, si un tratamiento es mejor que otro. Los ensayos se basan en estudios anteriores y en lo que se ha aprendido en el laboratorio. Cada ensayo responde a ciertas preguntas científicas para descubrir mejores maneras de ayudar a los pacientes con cáncer. Durante los ensayos clínicos de tratamiento, se recopila información sobre los efectos de un tratamiento nuevo y su eficacia. Si un ensayo clínico demuestra que un tratamiento nuevo es mejor que uno que se utiliza actualmente, el tratamiento nuevo puede convertirse en “estándar”. Participar en un ensayo clínico puede ser una opción para los pacientes. Algunos ensayos clínicos están abiertos solo a pacientes que aún no han comenzado el tratamiento.

Los ensayos clínicos se pueden encontrar en línea en el sitio web del NCI. Para obtener más información, llame al Servicio de Información sobre el Cáncer (CIS, por sus siglas en inglés), el centro de contacto del NCI, al 1-800-4-CANCER (1-800-422-6237).

Permiso de uso de este resumen

PDQ (Physician Data Query) es una marca registrada. Se autoriza el libre uso del contenido de los documentos del PDQ como texto. Sin embargo, no se podrá identificar como un resumen de información sobre cáncer del PDQ del NCI, salvo que se reproduzca en su totalidad y se actualice con regularidad. Por otra parte, se permite que los autores incluyan una oración como: “En el resumen del PDQ del NCI sobre la prevención del cáncer de mama se describen, de manera concisa, los siguientes riesgos: [incluir fragmento del resumen]”.

La forma recomendada para citar este resumen del PDQ es:

PDQ® Screening and Prevention Editorial Board. PDQ Breast Cancer Prevention. Bethesda, MD: National Cancer Institute. Updated <MM/DD/YYYY>. Available at: https://www.cancer.gov/types/breast/patient/breast-prevention-pdq. Accessed <MM/DD/YYYY>. [PMID: 26389410]

Las imágenes de este resumen se utilizan con el permiso del autor, artista y/o editorial para uso exclusivo en los resúmenes del PDQ. Si desea usar una imagen de un resumen del PDQ sin incluir el resumen completo, debe obtener autorización del propietario. El National Cancer Institute no puede otorgar dicho permiso. Para obtener más información sobre el uso de las imágenes de este resumen o de otras ilustraciones relacionadas con el cáncer, consulte Visuals Online, una colección de más de 3,000 imágenes científicas.

Descargo de responsabilidad

La información de estos resúmenes no debe utilizarse para tomar decisiones sobre reembolsos de seguros. Puede encontrar más información sobre la cobertura de seguros disponible en Cancer.gov/espanol en la página Manejo de la atención médica del cáncer.

Contáctenos

Puede encontrar más información sobre cómo contactarnos o recibir ayuda en el sitio web Cancer.gov en la página Contact Us for Help. También puede enviar sus preguntas a Cancer.gov en el apartado E-mail Us del sitio web.

Actualizado:

Este contenido ha sido facilitado por el National Cancer Institute (www.cancer.gov)
Detalles sobre el contenido distribuido:
Source URL: https://www.cancer.gov/node/4694/syndication
Agencia de origen: National Cancer Institute (NCI)
Fecha de captura: 2013-09-14 09:02:23.0